Sydney Adventist Hospital 02 9487 9111


Sydney Adventist Hospital
« View pages

Clinical Specialties & Services

Bladder Cancer Clinical Trials

BCG-MMC 

Adding Mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomized phase 3 trial “(BCG + MMC Trial)”

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364165

 

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services